The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.

  1. First select the CSR Section, then a Table/Figure from that section.
  2. Use the Submit button to view the table or figure. You will have options to download a printer-friendly version (PDF) or the data table (CSV) as well.

To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR (PDF, 533 KB) and Technical Notes (PDF, 752 KB) pages.



Download and Print: Download Printer-friendly PDF Download data


Table 1.29

Age-Adjusted U.S. Death Rates and Trends for the Top 15 Cancer Sitesa
Females by Race/Ethnicity
Race/Ethnicity Primary Site Age-Adjusted Rateb,
2007-2011
Trend (APC)c,
2002-2011
All Races All Sites 147.4 -1.4*
Lung and Bronchus 38.5 -1.2*
Breast 22.2 -2.0*
Colon and Rectum 13.5 -2.9*
Pancreas 9.6 0.4*
Ovary 7.9 -2.0*
Leukemia 5.3 -1.0*
Non-Hodgkin Lymphoma 5.0 -3.0*
Corpus and Uterus, NOS 4.3 0.8*
Brain and ONSf 3.5 -0.5*
Liver & IBDf 3.4 1.8*
Myeloma 2.7 -1.9*
Kidney and Renal Pelvis 2.6 -1.2*
Stomach 2.5 -2.7*
Cervix Uteri 2.3 -1.1*
Urinary Bladder 2.2 -0.6*
White All Sites 147.5 -1.4*
Lung and Bronchus 39.8 -1.1*
Breast 21.7 -2.0*
Colon and Rectum 13.0 -2.9*
Pancreas 9.4 0.5*
Ovary 8.2 -2.0*
Leukemia 5.4 -0.9*
Non-Hodgkin Lymphoma 5.2 -3.0*
Corpus and Uterus, NOS 4.0 0.7*
Brain and ONSf 3.8 -0.4
Liver & IBDf 3.2 1.9*
Kidney and Renal Pelvis 2.6 -1.2*
Myeloma 2.5 -1.9*
Urinary Bladder 2.2 -0.4
Stomach 2.1 -2.7*
Cervix Uteri 2.1 -0.8*
Black All Sites 169.0 -1.7*
Lung and Bronchus 36.5 -1.6*
Breast 30.6 -1.5*
Colon and Rectum 18.5 -3.2*
Pancreas 12.4 -0.2
Corpus and Uterus, NOS 7.5 1.0*
Ovary 6.6 -1.7*
Myeloma 5.3 -2.0*
Leukemia 4.8 -1.5*
Stomach 4.5 -3.5*
Liver & IBDf 4.2 1.7*
Cervix Uteri 4.1 -2.3*
Non-Hodgkin Lymphoma 3.5 -2.9*
Kidney and Renal Pelvis 2.6 -0.7
Urinary Bladder 2.6 -1.6*
Brain and ONSf 2.1 -0.2
Asian/
Pacific Islander
All Sites 91.5 -0.8*
Lung and Bronchus 18.4 -0.1
Breast 11.3 -1.6*
Colon and Rectum 9.5 -1.3*
Pancreas 7.2 0.5
Liver & IBDf 6.0 -1.4
Stomach 4.8 -4.0*
Ovary 4.7 -1.0
Non-Hodgkin Lymphoma 3.4 -2.0*
Leukemia 3.2 1.2
Corpus and Uterus, NOS 2.7 1.9*
Cervix Uteri 1.8 -3.0*
Brain and ONSf 1.5 0.9
Myeloma 1.4 -1.4
Kidney and Renal Pelvis 1.3 1.5
Oral Cavity and Pharynx 1.2 -2.6
American Indian/
Alaska Natived
All Sites 135.2 -1.6*
Lung and Bronchus 32.4 -1.5*
Colon and Rectum 15.6 0.0
Breast 15.2 -2.8*
Pancreas 8.0 0.8
Ovary 6.9 -0.3
Liver & IBDf 6.0 -2.4
Kidney and Renal Pelvis 4.4 -0.9
Non-Hodgkin Lymphoma 3.9 -3.2
Stomach 3.8 -6.3*
Leukemia 3.5 -3.7
Cervix Uteri 3.4 -2.2
Corpus and Uterus, NOS 3.4 -
Brain and ONSf 2.3 -
Myeloma 2.2 -5.6
Gallbladder 1.8 -4.4
Hispanice All Sites 99.9 -1.2*
Breast 14.5 -1.5*
Lung and Bronchus 14.0 -1.4*
Colon and Rectum 9.9 -2.1*
Pancreas 7.7 0.1
Ovary 5.6 -1.6*
Liver & IBDf 5.5 0.9*
Non-Hodgkin Lymphoma 4.4 -1.8*
Stomach 4.2 -2.8*
Leukemia 3.9 -0.5
Corpus and Uterus, NOS 3.4 1.5
Cervix Uteri 2.8 -2.4*
Brain and ONSf 2.4 -0.6
Kidney and Renal Pelvis 2.3 -0.7
Myeloma 2.3 -2.0*
Urinary Bladder 1.3 -1.7

Footnotes:

Source: US Mortality Files, National Center for Health Statistics, Centers for Disease Control and Prevention.

a Top 15 cancer sites selected based on 2007-2011 age-adjusted rates for the race/ethnic group.

b Rates are per 100,000 and age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130).

c The APC is the Annual Percent Change over the time interval. Trends are based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130).

d Rates for American Indian/Alaska Native are based on the CHSDA(Contract Health Service Delivery Area) counties.

e Hispanic is not mutually exclusive from whites, blacks, Asian/Pacific Islanders, and American Indians/Alaska Natives.

f IBD = Intrahepatic Bile Duct. ONS = Other Nervous System.

* The APC is significantly different from zero (p<.05).

- Statistic not shown. Rate based on less than 16 cases for the time interval. Trend based on less than 10 cases for at least one year within the time interval.

Page Navigation: << Previous Next >>


The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.